Trials / Completed
CompletedNCT03320096
Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ulthera, Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the Ulthera System and the 7-3.0mm transducer for treating axillary hyperhidrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Microfocused ultrasound with visualization | Subjects will receive 2 treatments (day 1 and day 30), each at a 3.0mm depth and 0.30 Joule of energy. Treatment will be delivered in a 3\*4 grid, 12 treatment squares, delivering 60 lines of treatment per square, i.e., 720 lines per axilla in each treatment (1440 lines total per treatment.) |
Timeline
- Start date
- 2016-12-13
- Primary completion
- 2017-06-19
- Completion
- 2017-08-22
- First posted
- 2017-10-25
- Last updated
- 2019-07-10
- Results posted
- 2019-07-10
Locations
2 sites across 1 country: Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03320096. Inclusion in this directory is not an endorsement.